About 7 results found for searched term "76-43-7" (0.055 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M2301 | NVP-TAE226 | FAK |
| TAE226 | ||
| Nvp-tae 226 (TAE226) is a potent atP-competitive dual FAK and IGF-1R inhibitor with IC50 of 5.5 nM and 140 nM, respectively. Nvp-tae 226 (TAE226) also effectively inhibited Pyk2, insulin receptor (InsR), with IC50 of 3.5 nM and 40 nM. | ||
| M4787 | Euphorbia-factor-L1 | Others |
| Euphorbia Factor L1, a diterpenoid compound, can reduce the protein and mRNA levels of Bcl-2, PI3K, AKT and mTOR, and up-regulate the protein levels of Caspase-9 and Caspase-3. There was no effect on caspase-9 and caspase-3 protease. Euphorbia Factor L1 can induce autophagy and has anti-cancer, anti-adipogenesis, anti-osteoclast formation and multiple drug resistance regulation effects. | ||
| M5657 | Fluoxymesterone | Androgen Receptor |
| Halotestin, Fluoximesterone, Testoral, Ora-Testryl | ||
| Fluoxymesterone is an Androgen. The mechanism of action of fluoxymesterone is as an Androgen Receptor Agonist. | ||
| M10090 | Latrunculin B | Antibiotic |
| LAT-B | ||
| Latrunculin B inhibits actin polymerization in vitro. Latrunculin B disrupts microfilament-mediated processes. | ||
| M17434 | Przewaquinone A | Quinones |
| Przewaquinone A | ||
| M30143 | Naveglitazar | PPAR |
| LY519818 | ||
| Naveglitazar (LY519818) is a nonthiozolidinedione peroxisome proliferator-activated receptor (PPAR) α-γ dual, γ-dominant agonist that has shown glucose-lowering potential in animal models. | ||
| M43377 | PI3Kδ-IN-16 | Apoptosis |
| PI3Kδ-IN-16 is a potent and selective inhibitor of PI3Kδ. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
